Equities

Clover Health Investments Corp

Clover Health Investments Corp

Actions
Health CareHealth Care Providers
  • Price (USD)0.7879
  • Today's Change-0.005 / -0.64%
  • Shares traded8.28m
  • 1 Year change-5.45%
  • Beta1.8481
Data delayed at least 15 minutes, as of Mar 28 2024 19:16 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Clover Health Investments, Corp. is a physician enablement company. The Company is focused on seniors who have historically lacked access to affordable healthcare. It offers a software platform, Clover Assistant, which is designed to aggregate patient data from across the health ecosystem to support clinical decision-making and improve health outcomes. The Company operates under two segments: Insurance and Non-Insurance. Through its Insurance segment, it provides Preferred Provider Organization (PPO) and Health Maintenance Organization (HMO) plans to Medicare Advantage (MA) members in several states. The Company's Non-Insurance segment consists of operations in connection with its participation in the Direct Contracting program. The Company’s subsidiaries include Clover Health Labs, LLC, Medical Service Professionals of NJ LLC, Clover HMO of New Jersey Inc., Clover Health Holdings, Inc. and Clover Health Partners, LLC.

  • Revenue in USD (TTM)2.03bn
  • Net income in USD-213.36m
  • Incorporated2021
  • Employees552.00
  • Location
    Clover Health Investments Corp3401 Mallory Lane, Suite 210, Suite 320FRANKLIN 37067United StatesUSA
  • Phone+1 (201) 432-2133
  • Fax+1 (302) 655-5049
  • Websitehttps://www.cloverhealth.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Domo Inc318.43m-76.70m332.85m967.00------1.05-2.16-2.168.96-4.121.50--5.87329,295.80-36.05-48.95---216.3676.5672.32-24.09-52.37---2.97----19.6523.25-3.37--1.03--
Innovid Corp139.88m-31.91m343.21m466.00--1.74--2.45-0.232-0.2321.011.390.549--3.11300,176.00-12.52---13.79--75.83---22.81------0.0926--10.04---73.34------
Stem Inc461.52m-140.41m345.52m624.00--0.8013--0.7487-0.9025-0.90252.972.730.332226.121.77739,607.40-10.11-13.00-12.43-14.980.8591---30.42-50.251.78-8.560.5579--27.15---13.19------
Rackspace Technology, Inc.2.96bn-837.80m347.21m5.80k------0.1174-3.92-3.9213.74-0.71070.6191--5.98509,844.80-17.54-7.48-21.22-8.5821.2631.04-28.33-15.52---0.23151.05---5.293.81-4.10---19.92--
PLAYSTUDIOS Inc310.89m-19.39m366.40m697.00--1.2614.171.18-0.1477-0.14772.272.140.8656--9.98446,034.40-5.40---6.08--74.9769.48-6.24-0.0013----0.00--7.099.72-9.05--5.87--
MMTec Inc3.22m-17.14m370.41m55.00--4.42--114.96-1.18-1.180.18410.42070.0482--1.1558,585.09-25.72-66.48-30.78-76.5111.5482.11-533.90-752.03---0.54240.5060--68.31--19.93---9.84--
American Software, Inc.107.04m10.25m380.37m402.0035.442.9025.933.550.32310.37623.163.950.58--3.65271,677.705.565.087.697.0963.2356.409.587.64----0.00159.82-3.051.87-18.47-0.7981-8.850.00
Backblaze Inc96.21m-62.00m382.02m393.00--8.04--3.97-1.79-1.792.781.260.6597--70.98244,804.10-42.51---70.27--48.31---64.44-----27.920.4543--26.19---136.81------
Clover Health Investments Corp2.03bn-213.36m392.77m552.00--1.35--0.1931-0.443-0.4434.230.58562.95--17.023,684,275.00-30.94---62.14-------10.49-----38.280.00---41.50--37.03------
Porch Group Inc430.30m-133.93m403.07m864.00------0.9367-1.40-1.404.48-0.36750.4417--16.97498,034.70-13.75---27.60--48.82---31.13-----5.051.09--55.94--14.45------
LifeMD Inc152.55m-23.70m410.93m207.00--111.10--2.69-0.7045-0.70454.500.09163.635.8537.61736,942.10-42.40-153.05-217.48-526.9187.6183.66-11.69-45.441.15-5.580.7663--28.1578.9051.27--143.64--
Health Catalyst Inc295.94m-118.15m435.71m728.00--1.18--1.47-2.10-2.105.256.290.407--5.47---16.25-20.34-18.42-23.4145.5648.23-39.92-50.43----0.3833--7.1321.3314.01--41.72--
Onespan Inc235.11m-29.80m442.90m676.00--2.76--1.88-0.7389-0.73895.874.240.75325.613.38347,789.90-9.55-4.12-14.95-5.5167.0867.25-12.67-6.361.14--0.00--7.352.15-106.45--27.76--
GDEV Inc.458.48m-65.34m454.00m848.00------0.9902-0.3387-0.21832.33-0.56491.33--12.28540,665.10-18.93---169.00--60.83---14.25-----0.7764----10.50--106.22------
Data as of Mar 28 2024. Currency figures normalised to Clover Health Investments Corp's reporting currency: US Dollar USD

Institutional shareholders

17.34%Per cent of shares held by top holders
HolderShares% Held
The Vanguard Group, Inc.as of 31 Dec 202323.95m5.99%
Renaissance Technologies LLCas of 31 Dec 202312.59m3.15%
BlackRock Fund Advisorsas of 31 Dec 20236.93m1.73%
PNC Bank, NA (Investment Management)as of 31 Dec 20235.11m1.28%
Geode Capital Management LLCas of 31 Dec 20234.26m1.07%
Jupiter Asset Management Ltd.as of 31 Dec 20233.83m0.96%
Two Sigma Investments LPas of 31 Dec 20233.63m0.91%
Susquehanna Financial Group LLLPas of 31 Dec 20233.45m0.86%
D. E. Shaw & Co. LPas of 31 Dec 20232.83m0.71%
Qube Research & Technologies Ltd.as of 31 Dec 20232.75m0.69%
More ▼
Data from 31 Dec 2023 - 31 Dec 2023Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.